NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/07/2022
Voltar para busca
Dado oficial do USPTO
INMEDIX INNOVATIVE MEDICAL DISCOVERY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000088317246Classe
9, 10, 35, 42, 44
Pedido
88317246
Registro
6782694
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
09/06/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 10, 35, 42, 44
Data de depósito
26/02/2019
Data de registro
05/07/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/07/2022
Última transação
09/06/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2006-12-00
Primeiro uso no comércio
2006-12-00
Código do desenho
3
Tipo de titular
03
Localização do titular
Normandy Park, WA, US
Examinador
CASE, LEIGH CAROLINE
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized words "INNOVATIVE MEDICAL DISCOVERY" beneath the stylized letters "INMEDIX" with an image of a stylized sun within a circle above the letter "I" in "INMEDIX".
Titulares e representantes
Titulares
Inmedix, Inc.
Representantes
Jonathan A. Menkes KNOBBE, MARTENS, OLSON & BEAR, LLP
Classificação técnica
Classes Nice
Classe 9Classe 10Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable software for patient monitoring; downloadable software for therapeutic purposespatient monitoring; downloadable software for diagnosingmonitoring or treating medical conditions; downloadable patient monitoring and diagnostic software for conducting stress research; tablet computer device and software sold as a unit for capturing patient data
Classe 10
Medical devices and instrumentspatient monitors and patient monitoring and diagnostic software sold as a unit; medical devices used for therapeutic purposespatient monitors and patient monitoring and diagnostic software sold as a unit; medical apparatus and instrumentspatient monitors and software for diagnosingmonitoring or treating medical conditions sold as a unit; medical apparatus and instrumentspatient monitors and patient monitoring and diagnostic software for conducting stress research sold as a unit
Classe 35
Business servicesbusiness research services and data collection that utilize artificial intelligencemachine learningbig data analytics for business purposes; data collection services in the field of healthcare and medicine; consulting services in the field of healthcare data collection and analytics; data collection for business purposes in the field of therapeuticspharmaceuticalsmedical devices; business consulting services in the field of healthcare and medicine; business research and data analysis services; conducting market research for others relating to medical devices and pharmaceuticals; conducting market research for others relating to medical devices; providing consumer purchasing information about medical devices and diagnostics
Classe 42
Providing online non-downloadable software for patient monitoring; providing online non-downloadable software for therapeutic purposespatient monitoring; providing online non-downloadable software for diagnosingmonitoring or treating medical conditions; providing online non-downloadable patient monitoring and diagnostic software for conducting stress research; scientific research and analysis services in the field of therapeuticspharmaceuticalsmedical devices; conducting new product research for others relating to therapeuticspharmaceuticalsmedical devices; consulting services in the field pharmaceutical research; medical research servicesconducting clinical trials for others; medical research services in the field of the autonomic nervous system; pharmaceutical research services; providing medical and scientific research information in the fields of pharmaceuticals and therapeutics; compiling data for research purposes in the field of medical science and medical consultancy; conducting scientific research for others relating to medical devices; consulting services in the fields of pharmaceutical research and developmentmedical device research and development and analytical testing; providing scientific information about medical devices and diagnostics; online non-downloadable medical device software for organizing patient recordscare coordination for use with medical data; computer technology consulting services in the field of data collection and analytics; data collection for medical research and diagnostic purposes in the field of therapeuticspharmaceuticalsmedical devices; providing medical testing for medical research purposes and commercialization; providing medical device softwaresoftware as a service (SAAS) services for analyzing human electrical signals for diagnostic purposes
Classe 44
Providing medical information; consulting services in the field of medical care; health assessment services; health counselling; medical clinic services; medical counseling; medical screening information services; providing health care information; providing health information; providing medical information to patients and medical professionals in the form of reports in the field of medical evaluations and diagnoses; providing medical testing for diagnostic or treatment purposes; providing personalized healthcare and medical information in the nature of the evaluationmanagement and prevention of medical conditionssymptoms and diseases; providing medical information about medical devices and diagnostics; medical diagnostic servicesdiagnosis of factors impacting autoimmune diseases and cancerdiagnosis of severity and treatment responses for autoimmune diseases and cancer
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
05/07/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
31/05/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
30/05/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/05/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/05/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/04/2022
IUAF
USE AMENDMENT FILED
15/03/2022
EISU
TEAS STATEMENT OF USE RECEIVED
15/03/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17/09/2021
EX2G
SOU EXTENSION 2 GRANTED
15/09/2021
EXT2
SOU EXTENSION 2 FILED
15/09/2021
EEXT
SOU TEAS EXTENSION RECEIVED
15/09/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16/03/2021
EX1G
SOU EXTENSION 1 GRANTED
12/03/2021
EXT1
SOU EXTENSION 1 FILED
12/03/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/03/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
15/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/07/2020
PUBO
PUBLISHED FOR OPPOSITION
21/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/07/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/06/2020
ALIE
ASSIGNED TO LIE
05/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/05/2020
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
28/04/2020
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
28/04/2020
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
28/04/2020
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
28/04/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
27/11/2019
GNFR
FINAL REFUSAL E-MAILED
27/11/2019
CNFR
FINAL REFUSAL WRITTEN
27/11/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/11/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/05/2019
GNRT
NON-FINAL ACTION E-MAILED
11/05/2019
CNRT
NON-FINAL ACTION WRITTEN
11/05/2019
DOCK
ASSIGNED TO EXAMINER
07/05/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
21/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/03/2019
NWAP
NEW APPLICATION ENTERED
01/03/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace INMEDIX INNOVATIVE MEDICAL DISCOVERY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.